retatrutide peptide dosage schedule Safety, Side Effects & Provider Use retatrutide dosing trial Reta clinical

Back Edwards, K, Li, X, Linvay, I (1 April 2023) 'Clinical and safety outcomes with GLP-1 receptor agonists and SGLT2 inhibitors in type 1 diabetes: A real-world study', The Journal of Clinical Endocrinology & Metabolism , 108/ 4, 92030

Hold the pen

They found widespread associations with the GLP-1 drugs and improvements to cognitive and behavioral health, with benefits including reduced risks of seizures, as well as a lower risk to addiction to substances such as alcohol, cannabis, stimulants and opioids

While these medications work through different mechanismssemaglutide via incretin pathways and levothyroxine through thyroid hormone replacementunderstanding their potential interactions is essential for safe, effective treatment

Once available, the 40mg option will sit alongside the existing vial sizes, giving more flexibility depending on individual protocol requirements

Why These Drugs Were Originally Created These medications were not developed for weight loss